Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD)

O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3373
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands). Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD). 3373

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood eosinophilia and the number of exacerbations in COPD patients
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014


Use of β-blockers and the risk of asthma exacerbations
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016


Outcomes of immunotherapy of patients with COPD
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Is therapy adherence with inhaled tiotropium in COPD related to hospitalization, pneumonia or mortality?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Guideline 2020
Year: 2020



Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Eur Respir J, 55 (6) 2000351; 10.1183/13993003.00351-2020
Year: 2020



Is therapy adherence to inhaled corticosteroids related to hospitalization, pneumonia or mortality in COPD?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Mortality after an acute exacerbation of COPD (AECOPD): findings from the National COPD Audit Programme
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Analysis of risk factors in children with asthma exacerbations treated at the National Institute of Respiratory Diseases ²Ismael Cosio Villegas² (INER)
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016


Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


COPD exacerbations and hospitalizations in COPDs with hypertension
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014

Safety and tolerability of acute dosing of beta-blockers in asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013

Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014


Effect of cardiac comorbidities on hospital mortality and duration of hospitalization in hospitalized COPD exacerbations
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014

Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Guideline adherence and cost of asthma treatment at emergency department
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit
Source: International Congress 2017 – COPD management
Year: 2017